Literature DB >> 14747736

Structural analysis of neprilysin with various specific and potent inhibitors.

Christian Oefner1, Bernard P Roques, Marie-Claude Fournie-Zaluski, Glenn E Dale.   

Abstract

Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic inactivation of a number of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin and atrial natriuretic factor. Owing to the physiological importance of NEP in the modulation of nociceptive and pressor responses, there is considerable interest in inhibitors of this enzyme as novel analgesics and antihypertensive agents. Here, the crystal structures of the soluble extracellular domain of human NEP (residues 52-749) complexed with various potent and competitive inhibitors are described. The structures unambiguously reveal the binding mode of the different zinc-chelating groups and the subsite specificity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747736     DOI: 10.1107/S0907444903027410

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  22 in total

Review 1.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

2.  An ab initio quantum mechanical drug designing procedure: application to the design of balanced dual ACE/NEP inhibitors.

Authors:  Nishi K Rao; Arpita Yadav; Sanjeev Kumar Singh
Journal:  J Mol Model       Date:  2009-05-09       Impact factor: 1.810

3.  Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity.

Authors:  Davide M Ferraris; Diego Sbardella; Agnese Petrera; Stefano Marini; Beat Amstutz; Massimo Coletta; Peter Sander; Menico Rizzi
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

Review 4.  Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.

Authors:  E Malito; R E Hulse; W-J Tang
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

5.  Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors.

Authors:  Toshio Kawanami; Rajeshri G Karki; Emma Cody; Qian Liu; Guiqing Liang; Gary M Ksander; Dean F Rigel; Nikolaus Schiering; Yongjin Gong; Gary M Coppola; Yuki Iwaki; Robert Sun; Alan Neubert; Li Fan; Sara Ingles; Allan D'Arcy; Frederic Villard; Paul Ramage; Arco Y Jeng; Jennifer Leung-Chu; Jing Liu; Michael Beil; Fumin Fu; Wei Chen; Frederic Cumin; Christian Wiesmann; Muneto Mogi
Journal:  ACS Med Chem Lett       Date:  2020-01-27       Impact factor: 4.345

Review 6.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

7.  Proteomic analysis (GeLC-MS/MS) of ePFT-collected pancreatic fluid in chronic pancreatitis.

Authors:  Joao A Paulo; Vivek Kadiyala; Linda S Lee; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  J Proteome Res       Date:  2012-02-07       Impact factor: 4.466

8.  Structures of soluble rabbit neprilysin complexed with phosphoramidon or thiorphan.

Authors:  Shaunivan L Labiuk; Jurgen Sygusch; Pawel Grochulski
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-05-10       Impact factor: 1.056

9.  Proposed Bioactive Conformations of Opiorphin, an Endogenous Dual APN/NEP Inhibitor.

Authors:  Marta Pinto; Catherine Rougeot; Luis Gracia; Mònica Rosa; Andrés García; Gemma Arsequell; Gregorio Valencia; Nuria B Centeno
Journal:  ACS Med Chem Lett       Date:  2011-11-17       Impact factor: 4.345

10.  Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.

Authors:  Randall W Velliquette; Kim Hue-Roye; Christine Lomas-Francis; Barbara Gillen; Jennifer Schierts; Kristie Gentzkow; Thierry Peyrard; Inge von Zabern; Willy A Flegel; Karen Rodberg; Asim K Debnath; Soohee Lee; Marion E Reid
Journal:  Transfusion       Date:  2013-04-08       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.